Blood work checks liver function through specific enzyme and protein measurements, primarily AST, ALT, alkaline phosphatase, bilirubin, and albumin. These markers reflect liver cell health, bile flow, and synthetic capacity. Abnormal levels indicate damage, inflammation, or obstruction.
Liver function tests are part of routine blood panels, often included in annual physicals or when symptoms like jaundice, fatigue, or abdominal pain arise. The most common tests assess liver enzymes released during cell stress or death. Elevated AST and ALT suggest hepatocyte injury-common in hepatitis, fatty liver disease, or medication toxicity. Alkaline phosphatase rises with bile duct issues, such as gallstones or primary biliary cholangitis. Bilirubin measures breakdown products of red blood cells; high levels signal impaired excretion or hemolysis.
Albumin, produced by the liver, reflects long-term function. Low levels may indicate chronic liver disease or malnutrition. Total protein and A/G ratio offer additional insight into synthetic capacity. These tests are not standalone diagnostics but part of a larger clinical picture.
When liver cells are damaged, they release enzymes like AST and ALT into the bloodstream. These enzymes are normally confined within cells. Their presence in blood indicates membrane leakage due to injury. Levels rise proportionally to the extent of damage, though not always linearly.
Bilirubin is formed when old red blood cells break down. The liver processes indirect bilirubin into direct form for excretion in bile. If the liver cannot process it, bilirubin accumulates, causing jaundice-yellowing of skin and eyes. High total bilirubin with elevated direct fraction suggests obstructive causes like tumors or stones. Isolated indirect elevation points to hemolysis or genetic disorders like Gilbert's syndrome.
Alkaline phosphatase is not liver-specific-it's also found in bone, placenta, and gut. But in liver tests, elevated levels often correlate with cholestasis-reduced bile flow. Imaging or further testing may be needed to confirm the cause.
The following table outlines standard reference ranges for adult liver function tests. Values vary slightly between labs, so each lab's reference interval should be consulted.
| Test | Normal Range (U/L) | What It Indicates |
|---|---|---|
| AST (SGOT) | 10-40 | Cellular damage; elevated in hepatitis, alcohol use, heart attack |
| ALT (SGPT) | 7-56 | Liver-specific injury marker; high in NAFLD, viral hepatitis |
| Alkaline Phosphatase | 44-147 | Bile duct obstruction; also elevated in bone growth or pregnancy |
| Total Bilirubin | 0.3-1.2 mg/dL | Impaired excretion or increased breakdown |
| Albumin | 3.5-5.0 g/dL | Long-term liver synthetic function; low in cirrhosis or malnutrition |
A single abnormal value doesn't diagnose disease. For example, mildly elevated ALT with normal AST may point to non-alcoholic fatty liver disease. AST/ALT ratio above 1 suggests alcoholic liver disease. A 2021 study in *Gastroenterology* found that AST/ALT ratios >1.5 had 82% sensitivity for identifying alcohol-related liver injury in primary care settings.
Many assume that elevated liver enzymes always mean serious illness. That's incorrect. Up to 15% of people with mild ALT elevations have no identifiable cause and remain stable over time. Some medications-like statins, acetaminophen, or certain antibiotics-can transiently raise enzymes without permanent harm.
Another misconception is that normal liver tests rule out liver disease. Not true. Early-stage fibrosis or steatohepatitis may show normal enzyme levels. FibroScan or elastography detects stiffness in the liver-indicating scarring-even when blood work is normal. The American Association for the Study of Liver Diseases (AASLD) recommends imaging or non-invasive testing when risk factors like obesity, diabetes, or heavy drinking exist, regardless of blood results.
Some patients confuse "liver function" with "liver detox." Detoxification is a metabolic role, but blood tests don't measure toxin clearance directly. Instead, they assess structural and functional integrity. The liver handles hundreds of metabolic tasks, but blood work focuses on measurable outputs.
In 2022, a 48-year-old woman presented with fatigue and mild right upper quadrant discomfort. Her blood work showed:
Her AST/ALT ratio was 0.61-below 1-suggesting non-alcoholic fatty liver disease (NAFLD) rather than alcohol-related injury. She had a BMI of 32, prediabetes, and no history of alcohol use. Ultrasound confirmed fatty infiltration. After lifestyle changes, her ALT dropped to 45 U/L in six months.
This case shows that patterns matter. Isolated ALT elevation with normal bilirubin and albumin often signals early NAFLD. The absence of cholestatic signs (elevated ALP, bilirubin) supports a diagnosis of metabolic liver disease.
If blood work reveals abnormal liver function, doctors typically repeat the test in 4-6 weeks to see if values normalize. Persistent elevation prompts further evaluation: ultrasound, FibroScan, or referral to a hepatologist. Autoimmune markers (ANA, SMA) may be ordered if autoimmune hepatitis is suspected.
For those with known liver conditions, regular monitoring prevents progression. Patients with hepatitis B or C undergo viral load testing alongside liver enzymes. Alcohol use screening is standard when AST exceeds 40 U/L.
Understanding your results requires context. A 2023 review in *The Lancet Gastroenterology & Hepatology* emphasized that clinicians must interpret lab values in light of patient history, medications, and comorbidities-not in isolation.